½ÃÀ庸°í¼­
»óǰÄÚµå
1391909

ÀÌÁú±Õ °Ë»ç ŰƮ ½ÃÀå : °Ë»ç À¯Çüº°, ±â¼úº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Shigella Test Kit Market, By Test Type (Lateral flow assays, Enzyme-linked immunosorbent assay, Polymerase chain reaction assay, and Others), By Technology, By EndUsers, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ÀÌÁú±Õ °Ë»ç ŰƮ ½ÃÀå ±Ô¸ð´Â 2023³â 1¾ï 640¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2023³âºÎÅÍ 2030³â±îÁö ¿¹Ãø ±â°£ µ¿¾È 5.9%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸À̸ç 2030³â¿¡´Â 1¾ï 5,890¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2022³â 2023³â ½ÃÀå ±Ô¸ð 1¾ï 640¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2018-2021³â ¿¹Ãø ±â°£ 2023-2030³â
¿¹Ãø ±â°£ÀÇ CAGR 5.90% 2030³â ½ÃÀå ±Ô¸ð ¿¹Ãø 1¾ï 5,890¸¸ ´Þ·¯
±×¸² 1. ÀÌÁú±Õ °Ë»ç ŰƮ ¼¼°è ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2023³â
Shigella Test Kit Market- IMG1

ÀÌÁú±Õ °Ë»ç ŰƮ´Â ÀÓ»ó ȯ°æ¿¡¼­ ÀÌÁú±ÕÀÇ Á¸À縦 °¨ÁöÇÏ´Â µ¥ »ç¿ëµÇ´Â °Ë»ç¿Í ŰƮ·Î ±¸¼ºµË´Ï´Ù. ÀÌ ¹ÚÅ׸®¾Æ´Â »ç¶÷ÀÇ ´ëº¯¿¡ Á¸ÀçÇÒ ¶§ ȯÀÚ¿¡°Ô ÀÌÁúº´À» À¯¹ßÇÏ°í ¼ö¾ç¼º ´ëº¯°ú ¹ß¿­°ú °°Àº ¼³»ç Áõ»óÀ» Ư¡À¸·ÎÇϸç, PCR ¹æ¹ýÀº ÁßÇÕ È¿¼Ò ¿¬¼â ¹ÝÀÀ(PCR) ±â¼úÀ» »ç¿ëÇÏ¿© Ç¥ÀûÀÇ µ¥ ¿Á½Ã ¸®º¸ ÇÙ»ê(DNA) ¼­¿­À» ÁõÆøÇÏ¿© °ËÃâ °¡´ÉÇÑ ½ÅÈ£¸¦ »ý¼ºÇÕ´Ï´Ù. ÀÌ °Ë»ç´Â ½Å¼ÓÇÏ°í °£ÆíÇÏ¸ç ºñ¿ë È¿À²ÀûÀÎ ÀÌÁú±Õ °Ë»ç¹ýÀÔ´Ï´Ù. ÀÌ °Ë»ç´Â »ì¸ð³Ú¶ó, įÇʷιÚÅÍ, ´ëÀå±Õ, Ŭ·Î½ºÆ®¸®µã µðÇǽǰú °°Àº ¹ÚÅ׸®¾Æ¿¡ ÀÇÇÑ ¼³»ç Áúȯ ¹× ±âŸ ÀÌÁú°ú À¯»çÇÑ °¨¿°À» È®ÀÎÇÏ´Â µ¥µµ À¯¿ëÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¿¹Ãø ±â°£ µ¿¾È ½ÃÀåÀº °­·ÂÇÑ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ¼ÒÈ­±â °¨¿° ¹× Áúº´ ¹ßº´·üÀÇ Áõ°¡ÀÔ´Ï´Ù. ¶ÇÇÑ, ¼ÒÈ­±â Áúȯ ¹× ¾Ï¿¡ ´ëÇÑ POC(Point of Care) °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌÁú °Ë»çÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â¼úÀûÀ¸·Î Áøº¸µÈ ºÐÀÚ Áø´ÜÀº ¼¼°è ÀÌÁú °Ë»ç ŰƮ ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

±×·¯³ª ½ÇÇè½Ç °Ë»ç¿¡ ºñÇØ ÀÌ Å°Æ®ÀÇ ³·Àº ¹Î°¨µµ´Â ¼¼°è ÀÌÁú±Õ °Ë»ç ŰƮ ½ÃÀåÀÇ ¼ºÀåÀ» Á¦ÇÑÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ÀÌ º¸°í¼­´Â 2022³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2023-2030³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR %)À» Á¦°øÇÏ´Â ¼¼°è ÀÌÁú±Õ °Ë»ç ŰƮ ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®ÇÕ´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®ÀÇ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ÆÄ¾ÇÇϰí ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾ÈÀÇ ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ ÁÖ¿ä ÀλçÀÌÆ®µµ Á¦°øÇÕ´Ï´Ù.
  • ȸ»ç ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú ¹× Àü·«°ú °°Àº ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ÀÌÁú±Õ °Ë»ç ŰƮ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°è ÀÌÁú±Õ °Ë»ç ŰƮ ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚ´Â ¼¼°è ÀÌÁú±Õ °Ë»ç ŰƮ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

  • Á¶»ç ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
  • ÀÌÁú±Õ °¨¿° ¹ß»ý·ü Áõ°¡
  • ÀÌÁú±Õ °¨¿°¿¡ ´ëÇÑ ÀÎ½Ä È®»ê
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ¾àÁ¦ ³»¼º Áõ°¡
    • ±âȸ
  • Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° ¹ß¸Å/½ÂÀÎ
  • PEST ºÐ¼®
  • Porters ºÐ¼®
  • ÇÕº´, Àμö ¹× Çù¾÷

Á¦4Àå ¼¼°èÀÇ ÀÌÁú±Õ °Ë»ç ŰƮ ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19) ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃø ºÐ¼®
  • °æÁ¦Àû ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ÀÌÁú±Õ °Ë»ç ŰƮ ½ÃÀå, °Ë»ç À¯Çüº°, 2018-2030³â

  • ¼­·Ð
  • Ãø¹æÀ¯µ¿¾î¼¼ÀÌ
  • È¿¼Ò°áÇÕ ¸é¿ªÈíÂø °ËÁ¤¹ý(ELISA)
  • ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ(PCR) ¾î¼¼ÀÌ
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ÀÌÁú±Õ °Ë»ç ŰƮ ½ÃÀå, ±â¼úº°, 2018-2030³â

  • ¼­·Ð
  • ±âÁ¸ Áø´Ü °Ë»ç
  • ÇÙ»ê ±â¹Ý °Ë»ç
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ÀÌÁú±Õ °Ë»ç ŰƮ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2018-2030³â

  • ¼­·Ð
  • º´¿ø
  • Áø´Ü ¿¬±¸¼Ò
  • ¿¬±¸±â°ü
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ÀÌÁú±Õ °Ë»ç ŰƮ ½ÃÀå, Áö¿ªº°, 2018-2030³â

  • ¼­·Ð
  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • À¯·´
  • ¿µ±¹
  • µ¶ÀÏ
  • ÇÁ¶û½º
  • ÀÌÅ»¸®¾Æ
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß±¹
  • ÀϺ»
  • Àεµ
  • È£ÁÖ
  • Çѱ¹
  • ASEAN ±¹°¡
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ºê¶óÁú
  • ¸ß½ÃÄÚ
  • ¾Æ¸£ÇîÆ¼³ª
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
  • GCC ±¹°¡
  • À̽º¶ó¿¤
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ºÏ¾ÆÇÁ¸®Ä«
  • Áß¾Ó¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï »óȲ

  • ±â¾÷ °³¿ä
    • Thermo Fisher Scientific Inc.
    • Meridian Bioscience Inc.
    • QIAGEN NV
    • Bio-Rad Laboratories Inc.
    • Creative Diagnostics
    • Hardy Diagnostics
    • Luminex Corporation
    • DiaSorin SpA
    • Sekisui Diagnostics LLC
    • BioMerieux SA
    • MP Biomedicals LLC
    • Coris BioConcept
    • Alere Inc.
    • Fujirebio Diagnostics Inc.
    • CTK Biotech Inc.

Á¦10Àå ¼½¼Ç

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç ¼Ò°³
ksm 23.12.15

Global shigella test kit market size is estimated to be valued at US$ 106.4 Mn in 2023 and is expected to reach US$ 158.9 Mn by 2030, exhibiting a compound annual growth rate (CAGR) of 5.9% during the forecast period of 2023-2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 106.4 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 5.90% 2030 Value Projection: US$ 158.9 Mn
Figure 1. Global Shigella Test Kit Market Share (%), By Region, 2023
Shigella Test Kit Market - IMG1

The shigella test kit consists of tests and kits used to detect the presence of shigella bacteria in a clinical setting. The bacterium, if present in human stool, causes the disease shigellosis in patients, which is characterized by diarrheal symptoms, such as watery stools and fever. It uses polymerase chain reaction (PCR) technology to amplify the target Deoxyribonucleic acid (DNA) sequence and produce a detectable signal, which is then read by a reader or analyzed by using a laboratory computer. It is a rapid, simple, and cost-effective method of testing for shigella. The test is also useful for identifying infections that are similar to shigellosis, including diarrheal illness and other infections which are caused by bacteria such as salmonella, campylobacter, E. coli, clostridium difficile, and others.

Market Dynamics:

The market is expected to grow at a strong pace over the forecast period. The market growth is driven by the increasing incidence of gastrointestinal infections and diseases. Rising demand for point of care (POC) testing for gastrointestinal disorders and cancers is also driving the market growth. Moreover, the increasing awareness about the benefits of shigella testing is again propelling the market growth. Furthermore, technologically advanced molecular diagnostics are further supporting the global shigella test kit market growth.

However, lower sensitivity of this kit as compared to the lab test is expected to restrict the market growth of the global shigella test kit market.

Key features of the study:

  • This report provides in-depth analysis of the global shigella test kit market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global shigella test kit market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Meridian Bioscience Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Creative Diagnostics, Hardy Diagnostics, Luminex Corporation, DiaSorin S.p.A., Sekisui Diagnostics LLC, BioMerieux SA, MP Biomedicals LLC, Coris BioConcept, Alere Inc., Fujirebio Diagnostics Inc., and CTK Biotech Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global shigella test kit market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global shigella test kit market

Detailed Segmentation:

  • Global Shigella Test Kit Market, By Test Type:
    • Lateral flow assays
    • Enzyme-linked immunosorbent assay (ELISA)
    • Polymerase chain reaction (PCR) assay
    • Others
  • Global Shigella Test Kit Market, By Technology
    • Conventional diagnostic tests
    • Nucleic acid-based tests
    • Others
  • Global Shigella Test Kit Market, By End Users
    • Hospitals
    • Diagnostic laboratories
    • Research institutes
    • Others
  • Global Shigella Test Kit Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Thermo Fisher Scientific Inc.
    • Meridian Bioscience Inc.
    • QIAGEN N.V.
    • Bio-Rad Laboratories Inc.
    • Creative Diagnostics
    • Hardy Diagnostics
    • Luminex Corporation
    • DiaSorin S.p.A.
    • Sekisui Diagnostics LLC
    • BioMerieux SA
    • MP Biomedicals LLC
    • Coris BioConcept
    • Alere Inc.
    • Fujirebio Diagnostics Inc.
    • CTK Biotech Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Test Type
    • Market Snippet, By Technology
    • Market Snippet, By End Users
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing incidence of shigella infections
  • Growing awareness about the shigella infections
    • Restraints
  • Increase in drug resistance
    • Opportunities
  • Government initiatives
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Shigella Test Kit Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Shigella Test Kit Market, By Test Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Lateral flow assays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Enzyme-linked immunosorbent assay (ELISA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Polymerase chain reaction (PCR) assay
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Global Shigella Test Kit Market, By Technology, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Conventional diagnostic tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Nucleic acid-based tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

7. Global Shigella Test Kit Market, By End Users, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Diagnostic laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Research institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

8. Global Shigella Test Kit Market, By Region, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2023 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Mn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • Company Profiles
    • Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Meridian Bioscience Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • QIAGEN N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Bio-Rad Laboratories Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Creative Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Hardy Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Luminex Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • DiaSorin S.p.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Sekisui Diagnostics LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • BioMerieux SA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • MP Biomedicals LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Coris BioConcept
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Alere Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Fujirebio Diagnostics Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • CTK Biotech Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦